DPLD诊断和治疗--讲义徐作军—培训课件.pptVIP

* * Completed Trials for IPF An increasing number of trials have been completed for IPF. Though valuable new data have been extracted about the disease, the trials have been largely negative and the yield of therapeutic options has been disappointing. The trials have been diverse in the primary endpoint, highlighting uncertainty about whether to rely on a clinical outcome such as mortality or physical function or a surrogate marker of pulmonary health such as FVC. * * Active or New Trials for IPF Active and new trials for IPF are listed on this slide. PANTHER is a large, well-controlled st